NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
Back to search
Official data from USPTO
A AARDVARK THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/12/2026
Trademark type
Combined
Nice classes
42
Filing date
11/17/2024
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/29/2019
First use in commerce
11/29/2019
Drawing code
3
Owner type
03
Owner location
San Diego, CA, US
Examiner
JUN, WON KYUNG WENDY
Law office
O40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording A AARDVARK THERAPEUTICS. The wording AARDVARK THERAPEUTICS appears in lower-case spelling on two lines with a stylized letter capital A to the left of the wording. The horizontal line in the letter A is replaced with a series of nine shaded circles in a curved line.
Holders and representatives
Holders
AARDVARK THERAPEUTICS, INC.
Representatives
Elise Wu Paul Hastings LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disordersmetabolic and inflammatory conditionsobesity and metabolic disordersPrader-Willi syndromehypothalamic obesity; providing medical and scientific research information in the fields of neuro psychological disordersmetabolic and inflammatory diseasesobesity and metabolic disordersPrader-Willi syndromehypothalamic obesity; medical and scientific researchconducting clinical trials for others for pharmaceuticalsdrug developmenttherapeutic applications in the fields of neuro psychological disordersmetabolic and inflammatory diseasesobesity and metabolic disordersPrader-Willi syndromehypothalamic obesity; clinical research in the field of neuro psychological disordersmetabolic and inflammatory diseasesobesity and metabolic disordersPrader-Willi syndromehypothalamic obesity
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/18/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/18/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/15/2026
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/15/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/03/2026
EX1G
SOU EXTENSION 1 GRANTED
04/03/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
04/03/2026
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
04/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/01/2026
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
04/01/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/01/2026
EXT1
SOU EXTENSION 1 FILED
03/31/2026
IUAF
USE AMENDMENT FILED
03/23/2026
DRRR
DIVISIONAL REQUEST RECEIVED
03/23/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/23/2026
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/23/2026
EEXT
SOU TEAS EXTENSION RECEIVED
03/23/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2025
PUBO
PUBLISHED FOR OPPOSITION
07/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2025
GNRT
NON-FINAL ACTION E-MAILED
05/14/2025
CNRT
NON-FINAL ACTION WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
05/12/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2025
NWAP
NEW APPLICATION ENTERED
11/17/2024
Continuous trademark protection
Get notified about every new filing that threatens A AARDVARK THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.